Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD)

Historical Holders from Q3 2024 to Q3 2025

Symbol
CVKD on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
1,783,394
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
114,193
Holdings value
$1,573,701
% of all portfolios
0%
Number of holders
17
Number of buys
8
Number of sells
-5
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Pham Quang X 23.6% $7,115,610 421,042 Quang X. Pham 23 Jan 2025
Havlickova 648 a.s. 4.39% $1,323,118 78,291 Havlickova 648 a.s. 31 Dec 2024
MURPHY JOHN RAYMOND 2.96% $899,164 53,205 John Raymond Murphy 31 Dec 2024

Institutional Holders of Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 114,193 $1,573,701 +$635,888 $13.83 17
2025 Q2 68,347 $823,305 -$12,430 $12.05 14
2025 Q1 69,304 $1,221,972 +$961,600 $17.63 13
2024 Q4 14,845 $215,103 +$214,451 $14.49 9
2024 Q3 5 $68 +$68 $13.6 1